jueves, 2 de julio de 2009

Donde no llega el VM...llega el MSL.


Un VM (Visitador Médico) todos sabemos que es...
Es algo "consustancial" con Salas de Espera en Centros de Salud, Ambulatorios, Hospitales. Es fácil identificarlo.



Un
MSL (Medical Science Liaisons) es más dificil de reconocer. Es de más "reciente creación".


Es como un "grupo comando", especializado en trabajos
"off-label"...


Fuera de "etiqueta" pero manteniéndola.




Son médicos, farmacéuticos y... no les gusta ser confundidos como "gente de ventas".


Lo suyo es otro "nivel".

Lo que llevan...tambien.

"MSLs bring additional value to a company because of their ability to help the company seek new uses for a drug, says Jane Chin, president of the MSL Institute, a company dedicated to the ethical training of MSLs."


Y la FDA lo consiente...


"Pharmaceutical companies are barred by the Food and Drug Administration from promoting unapproved drug uses, called off-label use, but they are using employees called "medical science liaisons," who are often physicians and pharmacists, as a legal way to discuss those uses.

Medical science liaisons (MSLs), who are considered medical rather than sales staff, have greater freedom than salespeople as they visit doctors offices to discuss the science behind a medicine, including unapproved uses.

The FDA permits drug companies to respond to unsolicited requests for information from doctors, including off-label data, if they provide truthful, nonpromotional material, says Rita Chappelle...

Su "número" crece año tras año:

"Though still small, the number of MSLs has increased steadily, totaling 1,970 in 2008, up 48% from 1,335 in 2003, according to data for 12 major pharmaceutical and biotech companies compiled by PharmaForce International, a market-research firm."


Novartis es uno de los que ha "comprado" el concepto:


"Novartis, which fields a large MSL force, told the paper that its MSLs aren't incentivized like sales people, for instance. And MSLs have more specialized training; they're often doctors or pharmacists. They're able to dig deeply into trial data, one MSL chief points out, and answer doctors' technical questions."

Ver...

Con información tomada de kaiserhealthnews.org



Ahora la FDA trata de poner "riendas"

No hay comentarios: